Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LURASIDONE HYDROCHLORIDE, with a corresponding US DMF Number 27970.
Remarkably, this DMF maintains an Active status since its submission on February 20, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 16, 2014, and payment made on February 25, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II